Rodríguez-Lara Simón Quetzalcoatl, Cardona-Muñoz Ernesto German, Ramírez-Lizardo Ernesto Javier, Totsuka-Sutto Sylvia Elena, Castillo-Romero Araceli, García-Cobián Teresa Arcelia, García-Benavides Leonel
Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, CUCS, Universidad de Guadalajara, Calle Sierra Mojada 950, Colonia Independencia, 44340 Guadalajara, Jal, Mexico.
Laboratorio de Neurofisiología, Departamento de Fisiología, CUCS, Universidad de Guadalajara, Calle Sierra Mojada 950, Colonia Independencia, 44340 Guadalajara, Jal, Mexico.
Oxid Med Cell Longev. 2016;2016:7190943. doi: 10.1155/2016/7190943. Epub 2016 Dec 28.
Ischemia/reperfusion (I/R) lesions are a phenomenon that occurs in multiple pathological states and results in a series of events that end in irreparable damage that severely affects the recovery and health of patients. The principal therapeutic approaches include preconditioning, postconditioning, and remote ischemic preconditioning, which when used separately do not have a great impact on patient mortality or prognosis. Oxidative stress is known to contribute to the damage caused by I/R; however, there are no pharmacological approaches to limit or prevent this. Here, we explain the relationship between I/R and the oxidative stress process and describe some pharmacological options that may target oxidative stress-states.
缺血/再灌注(I/R)损伤是一种发生于多种病理状态下的现象,会引发一系列最终导致不可修复性损伤的事件,严重影响患者的康复和健康。主要的治疗方法包括预处理、后处理和远程缺血预处理,单独使用时这些方法对患者死亡率或预后的影响不大。已知氧化应激会导致I/R造成的损伤;然而,目前尚无限制或预防这种损伤的药理学方法。在此,我们阐述I/R与氧化应激过程之间的关系,并描述一些可能针对氧化应激状态的药理学选择。